Spi Pharma

Overview

Spi Pharma is a pharmaceutical company headquartered in Wilmington, United States, with 201-500 employees.

Active pharmaceutical ingredients supplied

Substances Spi Pharma is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

Spi Pharma holds 3 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CALCIUM CARBONATE, MAG. HYDROXIDE GRANActive2024-06-14
• MAGNESIUM HYDROXIDE USP BARCROFT™ 5100 CG POWDERActive2024-03-06
• CALCIUM CARBONATE DC TYPE CS90 PRODUCTSActive2008-02-27
• ACTIMASK® IBUPROFEN 92SInactive2017-04-13
• BARCROFT™ 5100 CG MAGNESIUM HYDROXIDE POWDER USPInactive2015-06-23
• BULK ACTIMASK TASTE MASKED ACETAMINOPHENInactive2011-08-05
• MAGNESIUM HYDROXIDE DC MS90 PRODUCTSInactive2009-02-06
• BARCROFT(TM) 5300D MAGNESIUM HYDROXIDE USPInactive2006-04-07
• MAGNESIUM HYDROXIDE PASTE/POWDER USPInactive2001-03-19
• DRIED ALUMINUM HYDROXIDE GEL, USPInactive1998-10-01
• CALCIUM CARBONATE/STARCH GRANULATIONInactive1992-04-24
• MANNOGEM® MANNITOL USP PRODUCTSInactive1964-05-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Spi Pharma in our records. PharmaTek screens the full directory against live FDA enforcement data.